Source: Annual Congress 2007 - Venous thromboembolism
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kaya, H. C. Hasanoglu, A. Karalezli, E. Yeter (Ankara, Turkey). Efficiency of r-TPA therapy in major venous thromboembolism. Eur Respir J 2007; 30: Suppl. 51, 634

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Direct oral anticoagulants and venous thromboembolism Source: Eur Respir Rev 2016; 25: 295-302 Year: 2016 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Thrombolytic therapy in massive pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Therapeutic aspects of pulmonary embolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25 Year: 2004 Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Prophylaxis of venous thromboembolism : what is new? Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress Year: 2019 Venous thrombo-embolism prophylaxis Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009 Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing Source: Eur Respir J 2016; 47:1313-1314 Year: 2016 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Fever in venous thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020 Prospects for the prevention and treatment of venous thromboembolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155 Year: 2004 Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients Source: Eur Respir J 2004; 24: Suppl. 48, 273s Year: 2004 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004